GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (OTCPK:MROPF) » Definitions » Median PS Value

MROPF (MicroPort CardioFlow Medtech) Median PS Value : $0.00 (As of Dec. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort CardioFlow Medtech Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. MicroPort CardioFlow Medtech's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.022. MicroPort CardioFlow Medtech's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2024-12-15), MicroPort CardioFlow Medtech's share price is $0.1293. MicroPort CardioFlow Medtech's Median PS Value is $0.00. Therefore, MicroPort CardioFlow Medtech's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for MicroPort CardioFlow Medtech's Median PS Value or its related term are showing as below:

MROPF's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.79
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

MicroPort CardioFlow Medtech Median PS Value Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Median PS Value Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial - - - - -

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MicroPort CardioFlow Medtech's Median PS Value

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort CardioFlow Medtech's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's Price-to-Median-PS-Value falls into.



MicroPort CardioFlow Medtech Median PS Value Calculation

MicroPort CardioFlow Medtech's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.022*0
=0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MicroPort CardioFlow Medtech's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.022.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort CardioFlow Medtech  (OTCPK:MROPF) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

MicroPort CardioFlow Medtech's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.1293/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort CardioFlow Medtech Median PS Value Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort CardioFlow Medtech Business Description

Traded in Other Exchanges
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.